Buradasınız

Anasayfa » Content

RENAL TRANSPLANTIN DEĞERLENDİRİLMESİND E RADYONÜKLİD YÖNTEMLER

EVALUATION OF RENAL TRANSPLANT WITH RADIONUCLIDE TECHNIQUES

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2000

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
This article reviews the nuclear medicine techniques used in the evaluation of renal tranplant patients. We define the radiopharmacueticals used for monitoring renal transplant. Then we explain the different complications and scintigraphic techniques (methods and interpretation) in these situations. We also give some information about new and experimental procedures used for diagnosis with the guidance of literature.
Bookmark/Search this post with
Abstract (Original Language): 
Bu yazıda renal transplantm değerlendirilmesinde ve takibinde kullanılan nükleer tıp yöntemleri güncel literatürdeki bilgiler ışığında incelenmiştir. Genel olarak kullanılan radyofarmasötikler tanımlanmıştır. Daha sonra, ortaya çıkabilecek tablolar, bu durumlarda kullanılan radyonüklid yöntemler ve testin değerlendirilmesi anlatılmıştır. Ayrıca rutin kullanımda olmayan ve deneysel yöntemler hakında da bilgi verilmiştir.
FULL TEXT (PDF): 
PDF icon pdf_tndt_276.pdf
  • 1
8-13
  • Turkish

REFERENCES

References: 

1. Merrill JB, Murray JE, Harrison JR et al. Successful homotransplantation of the human kidney between identical twins. JAMA 1956, 160:277-282.
2. Massry SG and Glassock RJ. Textbook of Nephrology (3rd ed). Williams and Wilkins, Baltimore 1995,
ppl629-17l8.
3. Dubovsky EV. Evaluation of Renal Transplant. In: Henkin RE (ed). Nuclear Medicine. Mosby, Missouri 1996, pplO97-l 109.
4. Thomsen HS. Renal Transplant Evaluation. In: Murray IPC and Ell PJ. Nuclear Medicine in Clinical Diagnosis and Treatment. Churchill Livingstone 1994, pp339-351.
5. Mettler FA, Guiberteau MJ. Essentials of Nuclear Medicine Imaging (3rd ed). WB Saunders Company,
Philadelphia 1991, pp:237-251.
6. Dennis E, Alan RF. Radiopharmaceuticals for renal imaging. In: Henkin RE (ed). Nuclear Medicine. Mosby, Missouri 1996, pp 1055-1064.
7. Hilson AJW, Maisey MN, Brown CB, et al. Dynamic renal transplant imaging with Tc-99m DTPA (Sn) supplemented by a perfusion index in the management
of renal transplant. J Nucl Med 1978, 19:994-1000.
8. Eshima D, Taylor Jr. Technetium-99m mercaptoacetyltriglycine: uptade on new Tc-99m renal tubular function agent. Semin Nucl Med 1992, 22:61¬. : •'•7 3.
9. Kabasakal L, Turoğlu HT, Önsel Ç, et al. Clinical comparison of technetium 99m-EC, Tc-99m-MAG3 and iodine-131-OIH in renal disorders. J Nucl Med 1995,36:224-228.
10. Kirchner PT, Goldman MH, Leapmen SG, et al.
Clinical application of the kidney and aortic blood flow
index (K/A ratio). Contrib Nephrol 1978, 11:120-126.
11. Oei HY, Surachno S, Wümink JM, van der Schoot JB. Measurements of Tc-99m-MAG3 uptake in renal transplant recipient. In: Blaufox MD, Hollenberg NK, Raynaud C (eds). Radionuclides in nephro-urology.
Karger, Basel 1990; pp 113-117.
12. Bubeck B, Brandau W, Eisenhut N, et al. The tubular excretion rate (TER) of MAG3; a new qualitative parameter of renal function. Nucl Med Commun 1987;18:260-267.
13. Bubeck B, Brandau W, Weber E, et al.
Pharmacokinetics of Tc-99m-MAG3 in humans. J Nucl
Med 1990;31:1285-1293.
14. Preston DF, Luke RG. Radionuclide evaluation of renal
transplants. J Nucl Med 1979;20:1095-1097.
15. Jackson SA, Ehrlich L, Martin RH. Renal washout parameter as an indicator of transplant rejection. Eur J
Nucl Med 1986;12:86-90.
16. Peters AM, Gunasekara RD, Lavender JP et al. Noninvasive measurement of renal blood flow using DTPA radioisotope in nephro-urology. Contrib
Nephrol 1987,56:26-30.
17. Russell CD, Thorsad Bl, Yester MV, et al. Qantitation of renal fuction with Tc-99m MAG3. J Nucl Med.
1988;29:1931-1933.
18. Al-Nahhas AA, Jafri RA, Britton KE, et al. Clinical Experience with 99mTe-MAG3, mercaptoacetyltriglycine, and a comparison with
99mTc-DTPA, Eur J Nucl Med 1988; 14: 453-462.
19. Anaise D, Oster ZH, Atkins HL, et al: Cortex perfusion index: A sensitive dedector of acute rejection crisis in
transplanted kidneys. J Nucl Med 1986; 27: 1697-1701.
20. Baillet G, Ballarin J, Urdaneta N, et al: Evaluation of allograft perfusion by radionuclide first-pass study in renal failure following renal transplantation. Eur J Nucl
Med 1986; 11:463-469.
21. Yeboah ED, Chisholm GD Short MD. The detection
and prediction of acute rejection episodes in human transplants using radioactive fibrinogen. Br J Urol
1973;45:273-280.
22. Fawwaz RA, Johnson PM. Localization of Ga-67 in the normally functioning allografted kidney. J Nucl Med
1979;20:207-209.
23. Collier BD, Isitman AT, Kaufman HM, et al:
Concentration of In-111-oxine autologous leukocytes in noninfected and nonrejecting renal allografts (concise communication). J Nucl Med 1984; 25:156¬159.
24. Chandler ST, Buckels J, Hawker RJ. et al: Indium-
labeled platelet up-take in rejecting renal transplants.
Surg Gynecol Obstet 1983; 157:242-246.
25. Petrdy AE, Sutherland JB, Jeffery J et al. Renal
transplant uptake of Tc-99m-sulfur colloid in various time periods after transplantation. J Can Assoc. Radiol
1981;32:144-148.
26. George EA, Salimi A, Wolverson MK, Garvin PJ. Assesment of renal allograft pathology by scintigraphic and ultrasound index marker. Clin Nucl Med 1991;16:394-398.
27. DeKaski MC, Keane PF, Stuttle AWJ, Lavender JP,
Williams G, Peters AM: Antiplatelet monoclonal antibody P256 in the diagnosis of renal transplant
rejection. Clin Nucl Med 1991; 16:583-587.
13

Thank you for copying data from http://www.arastirmax.com